Nature webinar: VHH as building blocks for immune and tumour cell-targeting by Isogenica Webmaster | Sep 2023 | Bi-specific resources
From monoclonals to bi-specifics: Harnessing the transformative power of VHHs to supercharge IgG therapeutics by Isogenica Webmaster | Sep 2023 | Bi-specific resources
